Schnell David
SEC-identified person · CIK 1162060 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| NGM Biopharmaceuticals INC NGM | Director | filed 2019 - 2020 |
| Vitae Pharmaceuticals, Inc VTAE | Officer | filed 2014 - 2015 |
| Kythera Biopharmaceuticals INC KYTH | Director | filed 2012 - 2014 |
| Trans1 INC [BAXS] | Officer | filed 2013 - 2013 |
| Trubion Pharmaceuticals, Inc TRBN | Director | filed 2006 - 2010 |
| Hansen Medical INC HNSN | Officer | filed 2006 - 2007 |
| Amicus Therapeutics, INC. [FOLD} | Officer | filed 2007 - 2007 |
| Vanda Pharmaceuticals Inc. VNDA | Officer | filed 2006 - 2006 |
| Infinity Pharmaceuticals, INC. INFI | Officer | filed 2006 - 2006 |
| Senomyx INC SNMX | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.